![Becker Hewes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 7 M $ al 30/06/2026
Becker Hewes es Director Médico de Blueprint Medicines Corp. En su anterior carrera, el Dr. Hewes ocupó el cargo de Director Médico en Repertoire Immune Medicines, Inc. y Director Ejecutivo de Oncología Clínica Translacional en Novartis Institutes for Biomedical Research, Inc. Se doctoró en la Facultad de Medicina de la Universidad de Georgetown y se licenció en la Universidad de Vanderbilt.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/01/2026 | 264.629 ( 0,43 % ) | 7 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 05/01/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Director Técnico/Científico/I+D | 01/05/2020 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01/02/2017 |
| BLUEPRINT MEDICINES CORPORATION | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
